1. Home
  2. LGIH vs EVO Comparison

LGIH vs EVO Comparison

Compare LGIH & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo LGI Homes Inc.

LGIH

LGI Homes Inc.

HOLD

Current Price

$51.17

Market Cap

1.2B

ML Signal

HOLD

Logo Evotec SE

EVO

Evotec SE

HOLD

Current Price

$3.61

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LGIH
EVO
Founded
2003
1993
Country
United States
Germany
Employees
N/A
N/A
Industry
Homebuilding
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.1B
IPO Year
2013
2021

Fundamental Metrics

Financial Performance
Metric
LGIH
EVO
Price
$51.17
$3.61
Analyst Decision
Hold
Strong Buy
Analyst Count
6
1
Target Price
$75.90
$7.00
AVG Volume (30 Days)
439.2K
66.9K
Earning Date
02-17-2026
11-05-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
4.53
N/A
Revenue
$1,788,933,000.00
$887,396,457.00
Revenue This Year
N/A
N/A
Revenue Next Year
$18.60
$8.52
P/E Ratio
$11.29
N/A
Revenue Growth
N/A
N/A
52 Week Low
$39.70
$2.84
52 Week High
$97.25
$4.80

Technical Indicators

Market Signals
Indicator
LGIH
EVO
Relative Strength Index (RSI) 54.06 58.79
Support Level $50.95 $3.53
Resistance Level $55.28 $3.63
Average True Range (ATR) 3.08 0.08
MACD 0.23 -0.00
Stochastic Oscillator 63.63 59.46

Price Performance

Historical Comparison
LGIH
EVO

About LGIH LGI Homes Inc.

LGI Homes Inc is engaged in the design, construction, and sale of new homes in markets. The company current product offerings include entry-level homes, including both detached homes and townhomes, and move-up homes sold, which are sold under LGI Homes brand, and luxury series homes, which are sold under the Terrata Homes brand. It offers a set number of floor plans in each community with features that include upgrades, such as granite countertops, appliances, and ceramic tile flooring. The company have seven operating segments ( West, Northwest, Central, Midwest, Florida, Southeast and Mid-Atlantic) that it aggregates into five qualifying reportable segment. Majority of the revenue is generated from Central division segment.

About EVO Evotec SE

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.

Share on Social Networks: